Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
Anthropic's record-breaking IPO has Wall Street buzzing! GraniteShares CEO Will Rhind unpacks the AI stock frenzy, soaring valuations and bubble fears.
Robots are roaming grocery aisles! Simbe's Caitlin Allen joins us to unpack how AI-powered machines are changing shopping, stocking shelves and retail jobs.